Helicobacter pylori, Oxalobacter formigenes, and risk of kidney stones

Medical Hypotheses

Volumn 84, Issue 6, 2015, Pages 601-

  Goldfarb, David S ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; DISEASE ASSOCIATION; HELICOBACTER PYLORI; LETTER; NEPHROLITHIASIS; NONHUMAN; OXALOBACTER FORMIGENES; PREVALENCE; RISK FACTOR; STONE FORMATION; HELICOBACTER INFECTIONS; HUMAN; URINARY CALCULI;

HELICOBACTER PYLORI; OXALOBACTER FORMIGENES;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; URINARY CALCULI;

EID: 84933672600     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2015.03.005     Document Type: Letter

References (6)

1. Verit A., Guner N.D. Helicobacter pylori and urinary system stones: Endoluminal damage as sub-hypothesis to support the current stone theory. Med Hypotheses 2014, 83(6):677-680.
2. Kharlamb V., Schelker J., Francois F., Jiang J., Holmes R.P., Goldfarb D.S. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol 2011, 25(11):1781-1785.
3. Kaufman D.W., Kelly J.P., Curhan G.C., Anderson T.E., Dretler S.P., Preminger G.M., et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008, 19(6):1197-1203.
4. Scales C.D., Smith A.C., Hanley J.M., Saigal C.S. Prevalence of kidney stones in the United States. Eur Urol 2012, 62(1):160-165.
5. Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 2010, 12(2-3):e86-e96.
6. Blaser M.J., Falkow S. What are the consequences of the disappearing human microbiota?. Nat Rev Microbiol 2009, 7(12):887-894.